Afficher la notice abrégée

ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion

dc.rights.licenseopenen_US
dc.contributor.authorRIZZO, S.
dc.contributor.authorBARALE, P. O.
dc.contributor.authorAYELLO-SCHEER, S.
dc.contributor.authorDEVENYI, R. G.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDELYFER, Marie-Noelle
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorKOROBELNIK, Jean-Francois
dc.contributor.authorRACHITSKAYA, A.
dc.contributor.authorYUAN, A.
dc.contributor.authorJAYASUNDERA, K. T.
dc.contributor.authorZACKS, D. N.
dc.contributor.authorHANDA, J. T.
dc.contributor.authorMONTEZUMA, S. R.
dc.contributor.authorKOOZEKANANI, D.
dc.contributor.authorSTANGA, P. E.
dc.contributor.authorDA CRUZ, L.
dc.contributor.authorWALTER, P.
dc.contributor.authorAUGUSTIN, A. J.
dc.contributor.authorCHIZZOLINI, M.
dc.contributor.authorOLMOS DE KOO, L. C.
dc.contributor.authorHO, A. C.
dc.contributor.authorKIRCHHOF, B.
dc.contributor.authorHAHN, P.
dc.contributor.authorVAJZOVIC, L.
dc.contributor.authorIEZZI, Jr., R.
dc.contributor.authorGAUCHER, D.
dc.contributor.authorAREVALO, J. F.
dc.contributor.authorGREGORI, N. Z.
dc.contributor.authorGRISANTI, S.
dc.contributor.authorOZMERT, E.
dc.contributor.authorYOON, Y. H.
dc.contributor.authorKOKAME, G. T.
dc.contributor.authorLIM, J. I.
dc.contributor.authorSZURMAN, P.
dc.contributor.authorDE JUAN, Jr., E.
dc.contributor.authorREZENDE, F. A.
dc.contributor.authorSALZMANN, J.
dc.contributor.authorRICHARD, G.
dc.contributor.authorHUANG, S. S.
dc.contributor.authorMERLINI, F.
dc.contributor.authorPATEL, U.
dc.contributor.authorCRUZ, C.
dc.contributor.authorGREENBERG, R. J.
dc.contributor.authorJUSTUS, S.
dc.contributor.authorCINELLI, L.
dc.contributor.authorHUMAYUN, M. S.
dc.date.accessioned2021-02-25T13:59:38Z
dc.date.available2021-02-25T13:59:38Z
dc.date.issued2020
dc.identifier.issn1539-2864 (Electronic) 0275-004X (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26355
dc.description.abstractEnPurpose: To analyze and provide an overview of the incidence, management, and prevention of conjunctival erosion in Argus II clinical trial subjects and postapproval patients. Methods: This retrospective analysis followed the results of 274 patients treated with the Argus II Retinal Prosthesis System between June 2007 and November 2017, including 30 subjects from the US and European clinical trials, and 244 patients in the postapproval phase. Results were gathered for incidence of a serious adverse event, incidence of conjunctival erosion, occurrence sites, rates of erosion, and erosion timing. Results: Overall, 60% of subjects in the clinical trial subjects versus 83% of patients in the postapproval phase did not experience device- or surgery-related serious adverse events. In the postapproval phase, conjunctival erosion had an incidence rate of 6.2% over 5 years and 11 months. In 55% of conjunctival erosion cases, erosion occurred in the inferotemporal quadrant, 25% in the superotemporal quadrant, and 20% in both. Sixty percent of the erosion events occurred in the first 15 months after implantation, and 85% within the first 2.5 years. Conclusion: Reducing occurrence of conjunctival erosion in patients with the Argus II Retinal Prosthesis requires identification and minimization of risk factors before and during implantation. Implementing inverted sutures at the implant tabs, use of graft material at these locations as well as Mersilene rather than nylon sutures, and accurate Tenon's and conjunctiva closure are recommended for consideration in all patients.
dc.language.isoENen_US
dc.subjectLEHA
dc.title.enADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion
dc.title.alternativeRetinaen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1097/iae.0000000000002394en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed31972801en_US
bordeaux.journalRETINAen_US
bordeaux.page303-311en_US
bordeaux.volume40en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue2en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamLEHA_BPH
bordeaux.teamLEHA_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03152317
hal.version1
hal.date.transferred2021-02-25T13:59:45Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=RETINA&rft.date=2020&rft.volume=40&rft.issue=2&rft.spage=303-311&rft.epage=303-311&rft.eissn=1539-2864%20(Electronic)%200275-004X%20(Linking)&rft.issn=1539-2864%20(Electronic)%200275-004X%20(Linking)&rft.au=RIZZO,%20S.&BARALE,%20P.%20O.&AYELLO-SCHEER,%20S.&DEVENYI,%20R.%20G.&DELYFER,%20Marie-Noelle&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée